index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Human Umbilical Vein Endothelial Cells Molecular docking Dystrophin-EGFP Long QT Becker muscular dystrophy BMD Skeletal muscle Male LKB1 Autophagy Inhibitors Dystrophin central domain NNOS Cell homeostasis Molecular Sequence Data NAD+ Homeostasis Dynamin 2 Becker BMD muscular dystrophy Drp1 DMD Long noncoding RNA Cardiomyopathy Knockout Dystrophin DMO Antisense oligonucleotides Muscle development Animal/physiopathology DHPR α1S Duchenne muscular dystrophy L-Type Morphogenesis Muscles/physiopathology CD38 BMD Muscle Muscle Biology Multiresolution modeling Myogenesis Allele‐specific silencing therapy Invivo Animals Multi exon skipping Hepatocellular carcinoma Dystrophine Mdx mouse Dystrophie Musculaire de Duchenne DMD Inbred C57BL Delivery Gene Expression Regulation/drug effects Cachexia Myotendinous junction Muscle Strength Gene expression Genomic MES Muscular Dystrophy Gene modifiers Immunoglobulin Fc Fragments/pharmacology Liver CaVβs Muscular Atrophy Activin Receptors CaV subunits Exon skipping Clinical trials Ex-vivo Dystrophie Musculaire de Becker BMD Epigenetics CTNNB1 Centronuclear myopathy Dystrophie musculaire de Becker Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Duchenne DMD dystrophy Cell Line Base Sequence Modificateurs de gènes Calcium Diseases LncARN Becker muscular dystrophy Inbred mdx MiARN Calcium Channels Mice Dystrophy Metabolism Cell Biology Humans Multi resolution modeling LncRNA Génomique Duchenne muscular dystrophy DMD Cultured Hear Cardiomyopathie Mitochondrial fission Cells Energy Metabolism/drug effects Muscular dystrophy